Drug Database
Back to search

United States· US:0009-0047_9fdbd924-74fd-4b07-882c-d7e11b1a4642

SOLU-MEDROL

A medicinal product containing methylprednisolone sodium succinate, registered in United States by Pharmacia & Upjohn Company LLC.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSOLU-MEDROLATC—REGISTER NO.US:0009-0047_9fdbd924…PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about methylprednisolone sodium succinateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
METHYLPREDNISOLONE SODIUM SUCCINATE
Manufacturer
Pharmacia & Upjohn Company LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    0009-0047-04

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Methylprednisolone sodium succinate in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylprednisolone sodium succinate products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Solu-Medrol
  • Bulgaria · Метилпреднизолон Чайкафарма
  • Czechia · Solu-Medrol
  • Germany · Methylprednisolon Hikma, Metypred
  • Spain · Urbason
  • France · Methylprednisolone Hikma
  • United Kingdom (Northern Ireland) · Methylprednisolone Hikma Farmacêutica (Portugal), Methylprednisolone Pfizer
  • Hungary · Metilprednizolon Teva
  • Italy · Cortrium, Lisamethyle
  • Poland · Meprelon
  • Portugal · Metilprednisolona Hikma
  • Slovakia · Metylprednizolón Hikma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b1164e78-8643-4ec5-8d45-2045ce9da2dd
GET /v1/drugs/b1164e78-8643-4ec5-8d45-2045ce9da2dd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAMUSCULAR; INTRAVENOUS",
  "source": "ndc",
  "strength": "125",
  "substance": "METHYLPREDNISOLONE SODIUM SUCCINATE",
  "productndc": "0009-0047",
  "dosage_form": "INJECTION, POWDER, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/2mL",
  "application_number": "NDA011856",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about methylprednisolone sodium succinate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console